Skip navigation.

Achieving Undetectable: What Questions Remain in Scaling Up HIV Virologic Treatment Monitoring?

Corporate author: 
Médecins Sans Frontieres (MSF)
Publication details: 
Geneva, MSF, n.d.
Publication in: 
MSF Undetectable; Volume 6

A number of barriers may be hindering scale-up, including the price of viral load
testing, logistical and implementation barriers, and even potential costs incurred
from the higher price of second-line antiretrovirals (ARVs) as more patients
failing first-line treatment are identified. When addressing the task of introduction and use of routine virological monitoring, national HIV programmes and other implementers are faced with competing priorities, limited resources and logistical barriers. In this briefing document, Médecins Sans Frontières (MSF)
Access Campaign presents further evidence from a five-country study of viral load implementation and MSF’s own operational experience, to help respond to questions and concerns countries may face when planning viral load scale-up.